Bayer is a global life sciences company founded in 1863 in Barmen, Germany, operating across two main divisions: pharmaceuticals and crop science. The company has invested over $27 billion in research and development, positioning itself as a leader in addressing large-scale challenges including healthcare and food security.
In pharmaceuticals, Bayer developed Aspirin in the late 19th century, a breakthrough that established the company's foundation in modern medicine. The company continues to develop pharmaceutical solutions aimed at improving health outcomes globally.
The crop science division offers seeds, traits, and crop protection solutions designed to advance sustainable agriculture and enhance climate resilience. This portfolio addresses the dual imperatives of meeting global food demand while supporting more sustainable farming practices.
Under the leadership of CEO Bill Anderson, Bayer operates with a stated mission of "Health for all, Hunger for none," reflecting its commitment to tackling interconnected challenges in healthcare and agricultural sustainability through scientific innovation.